The MEB wishes to ensure that the information on this website is accessible to everyone. We therefore pay a great deal of attention to user-friendliness, accessibility, and findability.
The National decision regarding digital accessibility of websites and mobile applications of public sector bodies states that government websites must comply with accessibility requirements as determined in EN 301 549/WCAG 2.1 and must show their accountability by publishing an accessibility statement.
The Medicines Evaluation Board declares that the first measures have been taken to make the website Regulatory Science magazine compliant with the National decision regarding digital accessibility of websites and mobile applications of public sector bodies.
Go to the accessibility statement (in Dutch):
- to read the full, official statement
- to report an accessibility issue.
Overview of MEB accessibility statements
You can view accessibility statements that fall within the jurisdiction of the MEB in the registry of accessibility statements (in Dutch).
How do we work to ensure accessibility?
The MEB implements ongoing improvements in accessibility through a variety of measures within the framework of our (day-to-day) processes:
- Accessibility ‘by design’: from the very start, accessibility is integrated into all the steps of the design, construction, and editing process for our website. Within that context, we also focus specifically on user-friendliness and findability.
- Accessibility evaluations: independent experts regularly evaluate (parts of) the website from the perspective of accessibility. We resolve any bottlenecks or obstacles identified in a sustainable manner.
- Employee knowledge base: our employees regularly update their knowledge with regard to accessibility and apply new insights when necessary.
Reporting accessibility issues
Do you have any questions or comments? Or do you wish to make use of a page on this website that turns out not to be accessible? Then please contact us.Go to Regulatory Science